Authors
Latest:
How to Approach Parents Who Decline Vaccines for Their InfantsA 2-month-old baby is healthy and growing well, but when you begin to discuss immunizations, the parents stop you and state that they've decided not to immunize the child. How should you respond?
Latest:
HCPLive Presents the DocTalk PodcastThe DocTalk Podcast, a weekly conversation with leaders and experts in medicine, will launch with 3 new episodes on September 9.
Latest:
Do Patient-centered Medical Homes Really Improve Primary Care Quality?One patient-centered medical home pilot was associated with improvement in only one of 11 quality areas and was not associated with reductions in hospital utilization or costs of care over 3 years.
Latest:
Mortality of patients with diabetes mellitus and acute myocardial infarctionWe evaluated trends in the treatment and mortality of patients with and without diabetes mellitus and acute myocardial infarction over the last decade. Despite improvements in the provision of evidence-based care, patients with diabetes did not derive improvements in long-term survival.
Latest:
Sex-related differences in atrial fibrillation: Data from the RACE studyWe evaluated the effects of rate control treatment versus sinus rhythm restoration and maintenance in patients with persistent atrial fibrillation in a substudy of the Rate Control Versus Electrical Cardioversion (RACE) trial. Rhythm control treatment was associated with greater cardiovascular morbidity and mortality in women. Because treatment did not improve quality of life in these patients, rate control may be considered as first-choice therapy for women.
Latest:
The role of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease and preserved left ventricular systolic functionAngiotensin-converting enzyme (ACE) inhibitors have been shown to be beneficial in the management of multiple cardiovascular disease states.
Latest:
Reflecting on The Fight Against Cardiovascular Disease in 2021 with Simon Murray, MDDr. Simon Murray reflects on the ongoing fight against cardiovascular disease in the US as part of our coverage of American Heart Month.
Latest:
Why I Became A Concierge Medicine DoctorWhy should primary care physicians consider the concierge model of medicine? The question should really be rephrased: Why shouldn't they?
Latest:
Reduction of inflammatory biomarkers through the use of hyperlipidemia drugs in patients with diabetesDiabetes and inflammation influence the development of atherosclerosis. We performed a study that showed the inflammatory markers high-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 were lowered with the use of fenofibrate, simvastatin, and combination therapy. The anti-inflammatory effects were most pronounced among patients with elevated baseline inflammatory markers. Combination therapy significantly altered lipid concentrations and exerted a greater positive effect on low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides than monotherapy with either drug.
Latest:
What's in a Sign-out System Anyway?The author recalls how the digitization of a sign-out system greatly improved efficiency and reduced headaches among hospital staff, leading to the development of a custom system that further eased the pains of the sign-out process.
Latest:
NOW Initiative: Payer & Provider Collaborations in Oncology Benefits ManagementPayers recognize the need to expand benefits management for oncology but struggle to find effective solutions amid the complexity of available therapies and skepticism from oncologists, who are facing their own set of economic pressures. The National Oncology Working Group (NOW) Initiative is trying to change the sometimes adversarial relationship between payers and oncologists through a collaborative model.
Latest:
Warfarin versus aspirin for stroke prevention in the elderly study: Putting fears to restThe article by Mant and colleagues concerning the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study is a welcomed addition to the now vast literature regarding the relative benefits of warfarin anticoagulation in patients with atrial fibrillation.
Latest:
Changing Expectations: Using Online Tools to Get the LowdownOur expectations have changed a lot as we continue to see, every day, hundreds of tweets about current conditions.
Latest:
Should metformin be used to prevent diabetes in high-risk patients?As outlined by the authors, use of metformin is an appealing option because it is safe, produces few side effects, and is a cost-effective way to target some of the defects known to contribute to the metabolic defects associated with diabetes.
